Michael J. Vasconcelles

1.0k total citations
20 papers, 651 citations indexed

About

Michael J. Vasconcelles is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael J. Vasconcelles has authored 20 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael J. Vasconcelles's work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Michael J. Vasconcelles is often cited by papers focused on CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Michael J. Vasconcelles collaborates with scholars based in United States and Germany. Michael J. Vasconcelles's co-authors include Yide Jiang, Charles E. Martin, Mark A. Goldberg, James J. Rusthoven, U. Gatzemeier, Howard A. Burris, U. Keppler, Christian Manegold, J. Blatter and Giorgio V. Scagliotti and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael J. Vasconcelles

20 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Vasconcelles United States 9 255 220 178 90 84 20 651
Ichiro Ueno Japan 14 283 1.1× 116 0.5× 64 0.4× 67 0.7× 71 0.8× 36 555
Min Guan China 12 228 0.9× 73 0.3× 124 0.7× 30 0.3× 67 0.8× 28 532
Hiroko Mitsui Japan 15 249 1.0× 62 0.3× 111 0.6× 55 0.6× 61 0.7× 38 579
Fangyin Zeng China 11 295 1.2× 151 0.7× 133 0.7× 92 1.0× 41 0.5× 25 544
C. Decaens France 14 307 1.2× 113 0.5× 141 0.8× 92 1.0× 88 1.0× 32 688
Tatiana M. García-Bates United States 17 215 0.8× 85 0.4× 155 0.9× 175 1.9× 39 0.5× 20 622
Matthias Kist United States 7 560 2.2× 122 0.6× 134 0.8× 169 1.9× 105 1.3× 12 773
Sabine Strommer Austria 18 432 1.7× 112 0.5× 213 1.2× 139 1.5× 80 1.0× 25 769
Teresa K. Surowy United States 13 366 1.4× 61 0.3× 66 0.4× 141 1.6× 348 4.1× 20 1.0k
James A. Dowdle United States 6 439 1.7× 100 0.5× 86 0.5× 50 0.6× 49 0.6× 7 606

Countries citing papers authored by Michael J. Vasconcelles

Since Specialization
Citations

This map shows the geographic impact of Michael J. Vasconcelles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Vasconcelles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Vasconcelles more than expected).

Fields of papers citing papers by Michael J. Vasconcelles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Vasconcelles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Vasconcelles. The network helps show where Michael J. Vasconcelles may publish in the future.

Co-authorship network of co-authors of Michael J. Vasconcelles

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Vasconcelles. A scholar is included among the top collaborators of Michael J. Vasconcelles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Vasconcelles. Michael J. Vasconcelles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasconcelles, Michael J.. (2022). What’s next for real-world evidence in oncology?. The American Journal of Managed Care. 28(Spec. No. 3). SP142–SP143. 1 indexed citations
2.
3.
Motz, Greg, Kathleen R. Whiteman, Ann Ranger, et al.. (2018). Abstract B105: ACTR707: a novel T-cell therapy for the treatment of relapsed or refractory CD20+ B cell lymphoma in combination with rituximab. Molecular Cancer Therapeutics. 17(1_Supplement). B105–B105. 3 indexed citations
4.
5.
Huet, Heather, R. Anthony Barnitz, Kathleen E. McGinness, et al.. (2016). Targeting CD20+ Relapsed Refractory B Cell Lymphoma with ACTR087, Antibody-Coupled T-Cell Receptor (ACTR) Engineered Autologous T Cells, in Combination with Rituximab. Blood. 128(22). 3512–3512. 2 indexed citations
6.
Sekeres, Mikkael A., Gail J. Roboz, Olatoyosi Odenike, et al.. (2010). Preliminary Results of Fixed-Dose Oral Clofarabine (CLO) In Patients Who Have Failed Hypomethylating Agents for the Treatment of Myelodysplastic Syndromes (MDS). Blood. 116(21). 1869–1869. 3 indexed citations
7.
Avigan, David, Baldev Vasir, Daniel J. George, et al.. (2007). Phase I/II Study of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-derived Cells in Patients With Stage IV Renal Cell Carcinoma. Journal of Immunotherapy. 30(7). 749–761. 86 indexed citations
8.
Cunningham, Casey, John Nemunaitis, Neil Senzer, et al.. (2007). Effect of clofarabine on lymphocyte populations in patients treated for solid tumors. Journal of Clinical Oncology. 25(18_suppl). 21134–21134. 4 indexed citations
9.
Avigan, David, D. George, Philip W. Kantoff, et al.. (2004). Interim safety and efficacy results from a phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. Journal of Clinical Oncology. 22(14_suppl). 2526–2526. 3 indexed citations
10.
Avigan, David, Daniel J. George, Philip W. Kantoff, et al.. (2004). Interim safety and efficacy results from a phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. Journal of Clinical Oncology. 22(14_suppl). 2526–2526. 10 indexed citations
11.
Scagliotti, Giorgio V., Hedy L. Kindler, Michael J. Vasconcelles, et al.. (2003). Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma. Journal of Clinical Oncology. 21(8). 1556–1561. 200 indexed citations
12.
Jiang, Yide, et al.. (2002). Mga2p Processing by Hypoxia and Unsaturated Fatty Acids in Saccharomyces cerevisiae : Impact on LORE-Dependent Gene Expression. Eukaryotic Cell. 1(3). 481–490. 44 indexed citations
13.
Herbst, Roy S., C Lynch, Michael J. Vasconcelles, et al.. (2001). Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial. Cancer Chemotherapy and Pharmacology. 48(2). 151–159. 21 indexed citations
14.
Vasconcelles, Michael J., et al.. (2001). Identification and Characterization of a Low Oxygen Response Element Involved in the Hypoxic Induction of a Family ofSaccharomyces cerevisiae Genes. Journal of Biological Chemistry. 276(17). 14374–14384. 94 indexed citations
15.
Brown, Phil, et al.. (2001). Human cell- and tissue- based products: Progress, promise and regulatory issues. Journal of Commercial Biotechnology. 7(4). 2 indexed citations
16.
Jiang, Yide, et al.. (2001). MGA2 Is Involved in the Low-Oxygen Response Element-Dependent Hypoxic Induction of Genes in Saccharomyces cerevisiae. Molecular and Cellular Biology. 21(18). 6161–6169. 77 indexed citations
17.
18.
Fidias, P., Anthony Boral, AT Skarin, et al.. (2000). A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non-small cell lung cancer. Lung Cancer. 29(1). 57–57. 3 indexed citations
19.
Sekeres, Mikkael A., et al.. (2000). Two Patients With Sarcoma. Journal of Clinical Oncology. 18(11). 2341–2342. 9 indexed citations
20.
Vasconcelles, Michael J., et al.. (1990). Inhibition of Human Polymorphonuclear Leukocyte Respiratory Burst Activity and Aggregation by 6-Ketocholestanol. Free Radical Research Communications. 8(3). 185–193. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ichiro Ueno Breakdown of academic impact, for papers by Min Guan Breakdown of academic impact, for papers by Hiroko Mitsui Breakdown of academic impact, for papers by Fangyin Zeng Breakdown of academic impact, for papers by C. Decaens Breakdown of academic impact, for papers by Tatiana M. García-Bates Breakdown of academic impact, for papers by Matthias Kist Breakdown of academic impact, for papers by Sabine Strommer Breakdown of academic impact, for papers by Teresa K. Surowy Breakdown of academic impact, for papers by James A. Dowdle
Rankless by CCL
2026